Suchen Sie nach Informationen zu Clovis Onkologie-Zentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://clovisoncology.com/
Advancing the Fight Against Cancer. In our pursuit to improve the lives of people living with cancer, Clovis Oncology is committed to realizing the promise of precision medicine for cancer. We seek to develop targeted therapies to better serve patients and ensure the right drug gets to the right patient. Learn More.
https://clovisoncology.com/locations/
Clovis Oncology Locations. United States Locations. Company Headquarters. 5500 Flatiron Parkway, Suite 100 Boulder, CO 80301 . 303.625.5000 ...
https://clovisoncology.com/about/about-us/
Clovis Oncology is on a Mission to Advance the Fight Against Cancer. Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.Development Programs Are Focused on Providing the Right Drug, to the …
https://ir.clovisoncology.com/investors-and-news/news-releases/press-release-details/2022/Clovis-Oncology-Announces-First-Quarter-2022-Operating-Results-and-Provides-Update-on-Clinical-Development-Programs/default.aspx
Clovis expects selling, general and administrative expenses in the full year 2022 to be comparable to 2021. Clovis reported a net loss for Q1 2022 of $60.2 million, or ($0.44) per share, compared to a net loss for Q1 2021 of $66.3 million, or ($0.64) per share.
https://clovisoncology.com/pipeline/clinical-trials/
Learn More About Clovis Clinical Trials. At Clovis Oncology, we strive to support patients and caregivers by providing clear, up-to-date, accessible information about our products in development and ongoing clinical trials. For North America, Latin America and Asia Pacific inquires: 1-415-409-7220. 1-844-CLVS ONC (1-844-258-7662; U.S. toll-free)
https://clovisoncology.com/about/mission/
Advancing the Fight Against Cancer. In our pursuit to improve the lives of people living with cancer, Clovis Oncology is committed to realizing the promise of precision medicines for cancer. We seek to develop targeted therapies to better serve patients and ensure the right drug gets to the right patient.
https://ir.clovisoncology.com/investors-and-news/news-releases/press-release-details/2022/Clovis-Oncologys-Rubraca-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-Ovarian-Cancer-Regardless-of-Their-Biomarker-Status-in-Phase-3-ATHENA-MONO-Trial/default.aspx
https://ir.clovisoncology.com/investors-and-news/news-releases/press-release-details/2021/Clovis-Oncology-Announces-Partial-Adjournment-of-Annual-Meeting-of-Stockholders/default.aspx
Annual Meeting to be adjourned solely with respect to Proposal 2 (Increase in Authorized Shares of Common Stock) Both Leading Independent Advisory Firms Have Issued Favorable Recommendations on Proposal 2 Clovis Oncology, Inc. (NASDAQ:CLVS) (the “Company”) today announced partial results and the partial adjournment of its 2021 Annual …
https://www.uaru.wiki/detial/en/Clovis_Oncology
Clovis Oncology wurde 2009 von Patrick Mahaffy in Boulder, Colorado, gegründet. Das Unternehmen wurde zu Ehren des Mahaffy-Cache benannt, einer Sammlung von Steinwerkzeugen aus der Clovis-Zeit aus dem Jahr 11.000 v. Chr., die im Vorgarten von Mahaffys Haus in Boulder entdeckt wurden. Produktentwicklung Rociletinib
https://de.abcdef.wiki/wiki/Clovis_Oncology
Clovis Oncology ist ein amerikanisches Pharmaunternehmen, das hauptsächlich Produkte zur Behandlung in der Onkologie vertreibt . Clovis wurde 2009 gegründet und hat seinen Hauptsitz in Boulder, Colorado.Das Unternehmen ist ein börsennotiertes Unternehmen an der NASDAQ unter dem Symbol CLVS und ist mit mehreren Produkten in seiner Produktpipeline im NASDAQ …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Clovis Onkologie-Zentrale gefunden haben.
